학술논문
INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS
Document Type
Article
Author
Source
Retina; August 2022, Vol. 42 Issue: 8 p1568-1573, 6p
Subject
Language
ISSN
0275004X; 15392864
Abstract
This retrospective, comparative case series assesses the 10-year outcomes of intravitreal anti-VEGF injections with and without verteporfin photodynamic therapy for the treatment of choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.